Our Company's Umbilical Cord Mesenchymal Stem Cell Submission Successfully Enters the Drug Evaluation Process at the National Medical Products Administration
Our company's clinical registration application for umbilical cord mesenchymal stem cells has officially entered the evaluation process at the Center for……
Beike Biotech Approved to Establish a Shenzhen Postdoctoral Innovation Practice Base
Recently, Shenzhen Beike Biotechnology Co., Ltd. was approved by the Shenzhen Human Resources and Social Security Bureau to establish a Postdoctoral……
Beike Biotech Chairman Hu Xiang Attends and Chairs the Boao Life Industry Forum
On April 2, 2012, the Boao Life Industry Roundtable: "Life Industry — A Green Driver of the Global Economy" sub-forum was held at the Boao Golden Coast……
Warm Congratulations: Our Company's "High-Tech Industrialization of the Clinical Application of Mesenchymal Stem Cells" Project Recognized Under the National Torch Program
On October 14, 2011, news from the Ministry of Science and Technology indicates that our Technology R&D Center's submitted project, "High-Tech……
Beike Biotechnology Upgrades Its Processing and Cryopreservation Technology to Expedite Advancements in Stem Cell Therapies
Beike and ThermoGenesis Intend to Establish a “Center of Excellence” Showcase in Taizhou City TAIZHOU, China, March 16, 2011 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (“Beike”)……
Beike Biotech included in Shenzhen's three strategic emerging industry plans — Shenzhen seeks ways out of the 'ceiling dilemma'
Xinhuanet, Shenzhen, September 1 (reporter Peng Yong): Looking out from a high-rise in Shenzhen's central area, one sees the following scene: a winding……
Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania
New Center Integrates Traditional Chinese, Romanian and Western Therapies CAMPINA and PRAHOVA, Romania, July 20 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd.……
Beike Biotech Launches New International Stem Cell Venture
“Beike Holdings Limited”, a Strategic Joint Venture With Bangkok-Based SiriCell Technologies, Inc., Will Support the Rapid Clinical Translation of Stem Cell Therapies & Regulatory Approval Outside of……
Beike Biotechnology Opens World’s Largest Stem Cell Storage and Processing Facility
Leading Chinese Stem Cell Therapy Provider Expands Capacity Ahead of Schedule TAIZHOU, China, May 11 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the world’s leading biotechnology……
Beike Biotech's Stem Cell Technology Management System Passes ISO 9001 Certification
On January 26, 2010, Beike Biotech's stem cell preparation laboratory successfully passed ISO 9001 quality management system certification.…
Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to……
Beike CSO Speaks at IPA Diabetic Foot Care Conference, India
NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), spoke at a conference on……